Effect of in vitro gastrointestinal digestion on the chemical composition and antioxidant properties of Ginkgo biloba leaves decoction and commercial capsules

In this study leaves (GBL) decoction and commercial capsules were digested using an model. Thirty-six active compounds were identified and quantified by HPLC-ESI-MS analysis based on the MS/MS patterns (precursor ions and product ions) and retention times, in comparison with reference standards. Mos...

Full description

Saved in:
Bibliographic Details
Published in:Acta Pharmaceutica Vol. 72; no. 4; pp. 483 - 507
Main Authors: Zhou, Yubo, Yang, Yingxin, Ma, Minyan, Xie, Lingyun, Yan, Aijuan, Cao, Wen
Format: Journal Article Paper
Language:English
Published: Poland Sciendo 01-12-2022
De Gruyter Poland
Hrvatsko farmaceutsko društvo
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this study leaves (GBL) decoction and commercial capsules were digested using an model. Thirty-six active compounds were identified and quantified by HPLC-ESI-MS analysis based on the MS/MS patterns (precursor ions and product ions) and retention times, in comparison with reference standards. Most compounds in GBL showed a significant decrease during intestinal digestion, with an exception of vanillic acid and biflavonoids. Bioaccessibility values of chemical compositions varied between decoction and capsules samples. Also, significant reductions of total flavonoids and total phenolic content was observed after digestion. Both, 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis (3-ethylbenzothiazo-line-6-sulfonic acid (ABTS) scavenging capacity decreased after gastric digestion, but increased during intestinal digestion. Nevertheless, different behaviour was observed in reducing antioxidant power (FRAP) assay. Compared to the pH of digestion, the influence of digestive enzymes on the chemical composition and antioxidant activity of GBL was relatively minor. Overall, these results may help provide a valid foundation for further investigations on bioactive compounds and the pharmacodynamics of GBL.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
273436
ISSN:1846-9558
1330-0075
1846-9558
DOI:10.2478/acph-2022-0033